X

Stay Connected

Sign Up for Updates

network1.png

PPA strives to improve patient health, advance medical innovation and fuel economic growth.

LEARN MORE
network1.png

The PhRMA Foundation supports the research and career endeavors of scientists in drug discovery and development.

LEARN MORE
network1.png

Access Better Coverage educates consumers about the ABCs of health coverage and access to medicines.

LEARN MORE
network1.png

We Work For Health aims to increase awareness by uniting workers throughout the industry.

LEARN MORE
network1.png

Patent protection should always be considered by an inventor during the initial stages of their invention.

LEARN MORE
logo_white_MyOldMeds-New-1.png

Working to spread awareness and education about the importance of secure drug disposal.

LEARN MORE
LTAC_NEW21.png

Many Americans are struggling to afford their medicines and have important questions about their medicine costs. Let's Talk About Cost addresses these questions.

LEARN MORE
logo_white_LTAM.png

There are a lot of conversations in Washington about how to change Medicare Part D, but they aren't always focused on what seniors care about most: affordability and predictability.

LEARN MORE
 
We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

ICYMI: More than 60 PhRMA company scientists visit Capitol Hill

By Andrew Powaleny  |    September 30, 2016
Last week, PhRMA brought more than 60 member company researchers and scientists to Capitol Hill for a biopharmaceutical researcher fly-in. The fly-in highlighted the important science that’s...   Read More

Eradication of measles highlights the promise of vaccines in development

By Hannah Mooney Mack  |    September 29, 2016
On September 27, the Pan American Health Organization (PAHO) alongside the World Health Organization (WHO) announced that the Region of the Americas is the first region in the world to have...   Read More

Celebrating hope for patients and families on World Heart Day 2016

By Hannah Mooney Mack  |    September 29, 2016
My heart lives in Portland, Ore. The reason I do my work is there too. That’s where I grew up and where I saw my grandfather earlier this month. If you ask him how he is doing, he’ll say, “I’m doing...   Read More

4 recommendations for ICER

By Lauren Neves  |    September 26, 2016
For years, PhRMA has supported policies that ensure health care decisions are grounded in the best available evidence. In our policy solutions for delivering innovative treatments to patients...   Read More

Medicare Monday: New Part D study highlights benefit of switching plans

By Allyson Funk  |    September 26, 2016
With open enrollment beginning on October 15, it’s important for consumers to have adequate information to make the right decision about their health coverage and whether or not they should stay on...   Read More

340B Spotlight: Trends in shifting site of care

By Rachel Licata  |    September 21, 2016
Research has shown once health care services shift from a provider’s office to a hospital, treatment costs for payers and patients increase. One way hospitals drive this site of care shift is through...   Read More

New Survey: Patients’ share of health care costs continues to grow

By Allyson Funk  |    September 20, 2016
As we’ve highlighted before, a growing body of research continues to raise red flags about the implications of high cost sharing and patients’ ability to access affordable care – even if they have...   Read More

Patient voices missing from media conversation about prescription drug abuse

By Caitlin Carroll  |    September 19, 2016
Confronting and curtailing opioid abuse in America is a top public health priority and one to which PhRMA remains deeply committed. Mandating prescriber training, using state-based databases to...   Read More

Who gets a seat at ICER’s table? Hint: It’s not patients

By Holly Campbell  |    September 19, 2016
As we continue the move toward a value-driven health care system, efforts to develop tools supporting patient decision-making will play a central role. These tools, including emerging value...   Read More

Medicare Monday: New study highlights impact of variability in Medication Therapy Management programs

By Carolyn Ha  |    September 19, 2016
It’s almost the time of year for seniors to review their medications and select a Part D plan that best meets their needs. Included in Medicare Part D is the opportunity for qualifying beneficiaries...   Read More

2016 BCI Survey: A pro-innovation environment is essential for biopharmaceutical investment

By Guest Contributor  |    September 16, 2016
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

ICYMI: Multi-stakeholder group recommended changes to support value-driven health care

By Michelle Drozd  |    September 14, 2016
As part of PhRMA’s efforts to explore policy solutions to promote value-driven health care, we recently participated in a forum convened by Deloitte and the Network for Excellence in Health...   Read More

Medicare Monday: New research reveals Part D coverage is more robust than VA coverage for new, innovative medicines

By Allyson Funk  |    September 12, 2016
For 10 years, Medicare Part D has successfully provided access to affordable prescription drug coverage to seniors and people living with disabilities thanks to robust competition and negotiation...   Read More

New PhRMA report: New medicines in development for autoimmune diseases offer patients hope for brighter futures

By Hannah Mooney Mack  |    September 12, 2016
Currently, more than 23.5 million Americans are affected by one of the more than 80 autoimmune diseases identified to date. These diseases range in severity, with their own characteristics and their...   Read More

Are insurers exaggerating medicine costs to justify premium increases? Consumers think so.

By Robert Zirkelbach  |    September 9, 2016
Despite recent headlines, U.S. spending on prescription medicines continues to decline. In fact, new data from Altarum Institute found that spending on prescription medicines grew by just 3.9 percent...   Read More

Welcome to the new PhRMA.org

By Lauren DiPaola  |    September 8, 2016
We are excited to announce the launch of the new PhRMA.org. In partnership with our members, we’ve built this dynamic new platform for information, resources and multimedia content. The new website...   Read More

Making drug formulary search tools better for patients

By Rebecca Davison  |    September 7, 2016
There is a real need for patients to have information about out-of-pocket costs and clinical tools being used when it comes to their coverage. A new prescription drug search tool that includes...   Read More

Harnessing the power of real-world evidence to benefit patients through PDUFA VI

By Andrew Powaleny  |    September 6, 2016
America’s biopharmaceutical researchers are in a golden era of medical research, discovery and development for patients. Rapid advances in technology and science have enhanced our ability to use data...   Read More

Patients showcase longer, healthier lives in new “From Hope to Cures” ads

By Ieva M. Augstums  |    September 6, 2016
For Ed, a longer life meant more time with family, friends and his dog, BearBear. When he was diagnosed with colon cancer, he underwent six weeks of radiation, seven months of chemotherapy and 10...   Read More

Medicare Monday: Upcoming on the Medicare calendar

By Allyson Funk  |    September 5, 2016
What is coming up this week in the world of Medicare? Tune in to a couple of interesting happenings.   Read More

ICER puts hard-fought progress in non-small cell lung cancer treatment at risk

By Holly Campbell  |    September 1, 2016
Lung cancer is the leading cause of cancer death among men and women in the United States, and each year, tens of thousands of Americans are diagnosed with the most common form, non-small cell lung...   Read More

How modernizing FDA regulations can benefit patients, providers and payers

By Andrew Powaleny  |    September 1, 2016
Yesterday, the U.S. Food and Drug Administration (FDA) announced a two-day hearing slated for November 9 and 10, seeking public input as the agency works to review and potentially revise its policies...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Contributor

View Posts by Date

see all

Subscribe to Email Updates

Trending Posts

Most Popular Posts

Pharmaceutical Research and Manufacturers of America®
950 F Street, NW Suite 300, Washington, DC 20004

Please be advised that this page contains pixel tags. To learn more about what pixel tags are, why and how
we and third parties use pixel tags, and how that use affects you, visit our privacy policy and review
"1. Information Collection."